Abstract
No public abstract is available from the verified source records.
Colm B Collins
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
CB2R promotes T cell gut homing and exacerbates ileitis in a murine Crohn’s model
10.1093/ibd/izag066 · 2026
Treatment of active Crohn’s disease with MLN0002, a humanized antibody to the alpha4beta7 integrin
10.1016/j.cgh.2008.06.007 · 2008
Natalizumab for active Crohn’s disease
10.1056/nejmoa020732 · 2003
Cannabinoid receptor-2 ameliorates inflammation in murine model of Crohn’s disease
10.1093/ecco-jcc/jjx096 · 2017
Manipulation of the endocannabinoid system in colitis: a comprehensive review
10.1097/mib.0000000000001004 · 2017
The impact of cannabis use on clinical outcomes in inflammatory bowel disease: a population-based longitudinal cohort study
10.1093/ibd/izad151 · 2024
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease
10.1097/01.mib.0000440982.79036.d6 · 2014
Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study
10.1016/j.cgh.2013.04.034 · 2013
Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: a randomized controlled trial
10.1371/journal.pone.0246871 · 2021
No additional external references are available.